Government portal for the National Intellectual Property Office System

on September 15th, Tianjin Taipu Shanghai-Asia Intellectual Property Transfer Reserve Center was established in Tianjin Future Science and Technology City The center was jointly funded by Tianjin Pharmaceutical Research Institute and Shanghai-Asia Biointernational, and became the first international pharmaceutical patent transfer trading institution in our city.　　The establishment of the center has realized the combination of Tianjin Pharmaceutical Research Institute and the strong cooperation of the United States Shanghai-Asia Company, formed a global synchronous research and development mechanism of innovative pharmaceutical achievements, accelerated the two-way flow and development process of new pharmaceutical technologies, and brought a new mode of intellectual property operation The establishment of the center will further promote tianjin and national medical innovation and international connection, improve the development process of new chinese pharmaceutical technology.　　Chinese Academy of Engineering academician Yan Xishan, Chinese Academy of Engineering academician Liu Changxiao, Tianjin Intellectual Property Office Deputy Director Guo Ming, Binhai New Area Science and Technology Commission, Binhai High-tech Zone, Tianjin Biopharmaceutical Joint Research Institute, Tianjin Pharmaceutical Group, Tianjin Pharmaceutical Research Institute, Kuntai Corporation of the United States, Shanghai International Biotechnology Co., Ltd., in Tianjin University, research institutes, pharmaceutical industry guests participated in the listing activities september 19, 2014